Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease

Journal of Neural Transmission, Supplement

Volumn , Issue 65, 2003, Pages 63-71

  Munch G ^a,c   Gasic Milenkovic, J ^a   Arendt, T ^b  

^a Neuroimmunological Cell Biology Unit   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CARBONYL DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PRESENILIN 1; PRESENILIN 2; SUPEROXIDE; TENILSETAM; TRANSITION ELEMENT;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN CORTEX; CATALYSIS; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CONFERENCE PAPER; CROSS LINKING; CYTOKINE RELEASE; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; MICROGLIA; MITOGENESIS; MITOSIS INHIBITION; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SENILE PLAQUE; SIDE EFFECT; SIGNAL TRANSDUCTION; TRANSGENE; ANIMAL; METABOLISM; PATHOLOGY; REVIEW;

ALZHEIMER DISEASE; ANIMALS; CELL CYCLE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NEUROFIBRILLARY TANGLES; OXIDATIVE STRESS; SENILE PLAQUES; SIGNAL TRANSDUCTION;

EID: 0141906286     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0643-3_4     Document Type: Conference Paper

References (36)

1. Arendt T (1993) Neuronal de-differentiation and differentiation in Alzheimer's disease. Biol Chem Hoppe-Seyler 374: 911-912
2. Arendt T, Rodel L, Gärtner U, Holzer M (1996) Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7: 3047-3049
3. Braak H, Braak E (1995) Staging of Alzheimers disease-related neurofibrillary changes. Neurobiol Aging 16: 271-278
4. Braak H, Braak E, Bohl J, Reintjes R (1996) Age, neurofibrillary changes, a-beta-amyloid and the onset of Alzheimers disease. Neurosci Lett 210: 87-90
5. Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321-339
6. Dukic-Stefanovic S, Schinzel R, Riederer P, Münch G (2001) AGEs in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology 2: 19-34
7. Finch CE, Cohen DM (1997) Aging, metabolism, and Alzheimers disease - review and hypotheses. Exp Neurol 143: 82-102
8. Gärtner U, Holzer M, Heumann R, Arendt T (1995) Induction of p21ras in Alzheimer pathology. Neuroreport 6: 1441-1444
9. Gärtner U, Holzer M, Arendt T (1999) Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience 91: 1-5
10. Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS (1999) Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem 274: 19011-19016
11. Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS (2000) E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem 275: 11553-11560
12. Guh JY, Huang JS, Chen HC, Hung WC, Lai YH, Chuang LY (2001) Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1. Am J Kidney Dis 38: 1096-1104
13. Haass C (1997) Presenilins: genes for life and death. J Biol Chem 272: 7977-7982
14. Haass C, Hung AY, Selkoe DJ, Teplow DB (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem 269: 17741-17748
15. Klegeris A, Walker DG, McGeer PL (1997) Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase c-dependent secretion of tumor necrosis factor-alpha. Brain Res 747: 114-121
16. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814
17. Ledesma MD, Bonay P, Avila J (1995) Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 65: 1658-1664
18. Ledesma MD, Perez M, Colaco C, Avila J (1998) Tau glycation is involved in aggregation of the protein but not in the formation of filaments. Cell Mol Biol 44: 1111-1116
19. Li JJ, Voisin D, Quiquerez AL, Bouras C (1994) Differential expression of advanced glycosylation end-products in neurons of different species. Brain Res 641: 285-288
20. Loske C, Gerdemann A, Schepl W, Wycislo M, Schinzel R, Palm D, Riederer P, Münch G (2000) Transition metal mediated glycoxidation accelerates crosslinking of β-amyloid peptide. Eur J Biochem: 1-9
21. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP (1998) Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101: 1219-1224
22. Mehlhorn G, Hollborn M, Schliebs R (2000) Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci 18: 423-431
23. Münch G, Mayer S, Michaelis J, Hipkiss AR, Riederer P, Muller R, Neumann A, Schinzel R, Cunningham AM (1997) Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Acta 1360: 17-29
24. Münch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P (1998) Alzheimer's disease - synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 105: 439-461
25. Münch G, Luth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproducts - an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20: 253-257
26. Neumann A, Schinzel R, Palm D, Riederer P, Münch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappa B activation and cytokine expression. FEBS Lett 453: 283-287
27. Osuga H, Osuga S, Wang F, Fetni R, Hogan MJ, Slack RS, Hakim AM, Ikeda JE, Park DS (2000) Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci USA 97: 10254-10259
28. Price DL, Sisodia SS (1994) Cellular and molecular biology of Alzheimer's disease and animal models. Annu Rev Med 45: 435-446
29. Ruggiero-Lopez D, Rellier N, Lecomte M, Lagarde M, Wiernsperger N (1997) Growth modulation of retinal microvascular cells by early and advanced glycation products. Diabetes Res Clin Pract 34: 135-142
30. Satoh H, Togo M, Hara M, Miyata T, Han K, Maekawa H, Ohno N, Hashimoto Y, Kurokawa K, Watanabe T (1997) Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochem Biophys Res Comm 239: 111-115
31. Sayre LM, Perry G, Smith MA (1999) Redox metals and neurodegenerative disease. Curr Opin Chem Biol 3: 220-225
32. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M (1998) Overexpression of glyoxalase-i in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101: 1142-1147
33. Simm A, Münch G, Seif F, Schenk O, Heidland A, Richter H, Vamvakas S, Schinzel R (1997) Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1. FEBS Lett 410: 481-484
34. Thornalley PJ (1996) Pharmacology of methylglyoxal - formation, modification of proteins and nucleic acids, and enzymatic detoxification - a role in pathogenesis and antiproliferative chemotherapy. Gen Pharmacol 27: 565-573
35. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H (1997) Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272: 8723-8730
36. Yan SD, Zhu HJ, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM (1997) Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor - a proinflammatory pathway in Alzheimer-disease. Proc Natl Acad Sci USA 94: 5296-5301